246 related articles for article (PubMed ID: 36057424)
21. Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction.
Zhang W; Flemington EK; Deng HW; Zhang K
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):198-207. PubMed ID: 30262601
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.
White-Al Habeeb NM; Ho LT; Olkhov-Mitsel E; Kron K; Pethe V; Lehman M; Jovanovic L; Fleshner N; van der Kwast T; Nelson CC; Bapat B
Oncotarget; 2014 Sep; 5(17):7858-69. PubMed ID: 25277202
[TBL] [Abstract][Full Text] [Related]
23. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
25. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
27. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
Etcheverry A; Aubry M; de Tayrac M; Vauleon E; Boniface R; Guenot F; Saikali S; Hamlat A; Riffaud L; Menei P; Quillien V; Mosser J
BMC Genomics; 2010 Dec; 11():701. PubMed ID: 21156036
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer.
Reynolds SR; Zhang Z; Salas LA; Christensen BC
Clin Epigenetics; 2024 Jan; 16(1):5. PubMed ID: 38173042
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
[TBL] [Abstract][Full Text] [Related]
32. Comparative DNA methylation and gene expression analysis identifies novel genes for structural congenital heart diseases.
Grunert M; Dorn C; Cui H; Dunkel I; Schulz K; Schoenhals S; Sun W; Berger F; Chen W; Sperling SR
Cardiovasc Res; 2016 Oct; 112(1):464-77. PubMed ID: 27496870
[TBL] [Abstract][Full Text] [Related]
33. Gene Set Based Integrated Methylome and Transcriptome Analysis Reveals Potential Molecular Mechanisms Linking Cigarette Smoking and Related Diseases.
Mishra PP; Mishra BH; Raitoharju E; Mononen N; Viikari J; Juonala M; Hutri-Kähönen N; Kähönen M; Raitakari OT; Lehtimäki T
OMICS; 2023 May; 27(5):193-204. PubMed ID: 37145884
[TBL] [Abstract][Full Text] [Related]
34. PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.
Wang C; Feng Y; Zhang C; Cheng D; Wu R; Yang Y; Sargsyan D; Kumar D; Kong AN
FASEB J; 2020 Jan; 34(1):1304-1318. PubMed ID: 31914691
[TBL] [Abstract][Full Text] [Related]
35. A DNA methylation profile of long non-coding RNAs can predict OS in prostate cancer.
Cheng W; Cao J; Xia Y; Lei X; Wu L; Shi L
Bioengineered; 2021 Dec; 12(1):3252-3262. PubMed ID: 34238128
[TBL] [Abstract][Full Text] [Related]
36. Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature.
Zhang E; Shiori F; Mu OY; He J; Ge Y; Wu H; Zhang M; Song Y
Front Cell Dev Biol; 2021; 9():639615. PubMed ID: 33708770
[TBL] [Abstract][Full Text] [Related]
37. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.
Paziewska A; Dabrowska M; Goryca K; Antoniewicz A; Dobruch J; Mikula M; Jarosz D; Zapala L; Borowka A; Ostrowski J
Br J Cancer; 2014 Aug; 111(4):781-9. PubMed ID: 24937670
[TBL] [Abstract][Full Text] [Related]
39. Prediction of epigenetically regulated genes in breast cancer cell lines.
Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
[TBL] [Abstract][Full Text] [Related]
40. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
